OP7 EFFICACY, SAFETY, AND TOLERABILITY OF IPRAGLIFLOZIN IN ASIAN TYPE 2 DIABETIC PATIENTS WITH INADEQUATE GLYCEMIC CONTROL WITH METFORMIN. RESULTS OF A PHASE 3 RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, MULTICENTER TRIAL

Phase 3 ◽

Double Blind ◽

Type 2 Diabetic ◽

Dapagliflozin Monotherapy in Type 2 Diabetic Patients With Inadequate Glycemic Control by Diet and Exercise: A randomized, double-blind, placebo-controlled, phase 3 trial

Diabetes Care ◽

10.2337/dc10-0612 ◽

2010 ◽

Vol 33 (10) ◽

pp. 2217-2224 ◽

Cited By ~ 444

Author(s):

E. Ferrannini ◽

S. J. Ramos ◽

A. Salsali ◽

W. Tang ◽

J. F. List

Keyword(s):

Glycemic Control ◽

Diabetic Patients ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Diet And Exercise ◽

Type 2 Diabetic ◽

Effects of dapagliflozin on serum uric acid levels in hospitalized type 2 diabetic patients with inadequate glycemic control: a randomized controlled trial

Therapeutics and Clinical Risk Management ◽

10.2147/tcrm.s186347 ◽

2018 ◽

Vol Volume 14 ◽

pp. 2407-2413 ◽

Cited By ~ 3

Author(s):

Zhaohu Hao ◽

Xiao Huang ◽

Hailin Shao ◽

Fengshi Tian

Keyword(s):

Randomized Controlled Trial ◽

Uric Acid ◽

Glycemic Control ◽

Controlled Trial ◽

Diabetic Patients ◽

Randomized Controlled ◽

Type 2 Diabetic ◽

Efficacy, safety, and tolerability of ipragliflozin in Asian patients with type 2 diabetes mellitus and inadequate glycemic control with metformin: Results of a phase 3 randomized, placebo‐controlled, double‐blind, multicenter trial

Journal of Diabetes Investigation ◽

10.1111/jdi.12422 ◽

2015 ◽

Vol 7 (3) ◽

pp. 366-373 ◽

Cited By ~ 37

Author(s):

Chieh‐Hsiang Lu ◽

Kyung Wan Min ◽

Lee‐Ming Chuang ◽

Satoshi Kokubo ◽

Satoshi Yoshida ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Glycemic Control ◽

Multicenter Trial ◽

Phase 3 ◽

Double Blind ◽

Asian Patients ◽

Treatment for 6 months with fish oil-derived n-3 polyunsaturated fatty acids has neutral effects on glycemic control but improves dyslipidemia in type 2 diabetic patients with abdominal obesity: a randomized, double-blind, placebo-controlled trial

European Journal of Nutrition ◽

10.1007/s00394-016-1352-4 ◽

2016 ◽

Vol 56 (7) ◽

pp. 2415-2422 ◽

Cited By ~ 16

Author(s):

Feng Wang ◽

Yanyan Wang ◽

Yan Zhu ◽

Xiaosong Liu ◽

Hui Xia ◽

...

Keyword(s):

Fatty Acids ◽

Glycemic Control ◽

Fish Oil ◽

Controlled Trial ◽

Diabetic Patients ◽

Double Blind ◽

Double Blind Placebo ◽

A double-blind randomized comparison of meal-related glycemic control by repaglinide and glyburide in well-controlled type 2 diabetic patients

Diabetes Care ◽

10.2337/diacare.22.5.789 ◽

1999 ◽

Vol 22 (5) ◽

pp. 789-794 ◽

Cited By ~ 87

Author(s):

P. Damsbo ◽

P. Clauson ◽

T. C. Marbury ◽

K. Windfeld

Keyword(s):

Glycemic Control ◽

Diabetic Patients ◽

Double Blind ◽

Efficacy and Safety of Taspoglutide Monotherapy in Drug-Naive Type 2 Diabetic Patients After 24 Weeks of Treatment: Results of a randomized, double-blind, placebo-controlled phase 3 study (T-emerge 1)

Diabetes Care ◽

10.2337/dc11-1942 ◽

2012 ◽

Vol 35 (3) ◽

pp. 485-487 ◽

Cited By ~ 27

Author(s):

I. Raz ◽

V. Fonseca ◽

M. Kipnes ◽

L. Durrwell ◽

J. Hoekstra ◽

...

Keyword(s):

Diabetic Patients ◽

Efficacy And Safety ◽

Treatment Results ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Drug Naïve ◽

Status of basal-supported oral therapy in Chinese type 2 diabetic patients with inadequate glycemic control on oral anti-diabetic drugs

Diabetes/Metabolism Research and Reviews ◽

10.1002/dmrr.2709 ◽

2015 ◽

Vol 31 (8) ◽

pp. 796-802

Author(s):

Wen Xu ◽

Liling Qiu ◽

Sihui Luo ◽

Ming Li ◽

Jianping Weng ◽

...

Keyword(s):

Glycemic Control ◽

Oral Therapy ◽

Diabetic Patients ◽

Basal Supported Oral Therapy ◽

Type 2 Diabetic ◽

The effect of different antihypertensive treatment protocoles on glycemic control and lipid profile in type 2 diabetic patients with microalbuminuria and stage 1 hypertension

Endocrine Abstracts ◽

10.1530/endoabs.49.ep533 ◽

2017 ◽

Author(s):

Muge Erek ◽

Alparslan Ersoy ◽

Canan Ersoy

Keyword(s):

Glycemic Control ◽

Lipid Profile ◽

Antihypertensive Treatment ◽

Diabetic Patients ◽

Stage 1 ◽

Six months of retrospective glycemic control and anthropometric outcomes in type 2 diabetic patients with new dapagliflozin treatment; actual clinical experience data from single center

Endocrine Abstracts ◽

10.1530/endoabs.56.p491 ◽

2018 ◽

Author(s):

Soner Cander ◽

Murat Calapkulu ◽

Ozen Oz Gul ◽

Canan Ersoy

Keyword(s):

Glycemic Control ◽

Clinical Experience ◽

Diabetic Patients ◽

Single Center ◽

Is there a relation between statin use and glycemic control in type 2 diabetic patients?

Türkiye Aile Hekimliği Dergisi ◽

10.15511/tahd.15.02179 ◽

2015 ◽

Vol 19 (4) ◽

pp. 179-186

Author(s):

Altuğ Kut ◽

Yusuf Boşkuş ◽

Özgür Çaycı ◽

Ali Ümit Geçkil

Keyword(s):

Glycemic Control ◽

Diabetic Patients ◽

Type 2 Diabetic ◽

Statin Use